|
1
|
Lheureux S, Gourley C, Vergote I and Oza
AM: Epithelial ovarian cancer. Lancet. 393:1240–1253. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Reid BM, Permuth JB and Sellers TA:
Epidemiology of ovarian cancer: A review. Cancer Biol Med. 14:9–32.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Deng J, Wang L, Chen H, Hao J, Ni J, Chang
L, Duan W, Graham P and Li Y: Targeting epithelial-mesenchymal
transition and cancer stem cells for chemoresistant ovarian cancer.
Oncotarget. 7:55771–55788. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Feng RM, Zong YN, Cao SM and Xu RH:
Current cancer situation in China: Good or bad news from the 2018
Global Cancer Statistics? Cancer Commun (Lond). 39:222019.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chu YH, Sibrian-Vazquez M, Escobedo JO,
Phillips AR, Dickey DT, Wang Q, Ralle M, Steyger PS and Strongin
RM: Systemic Delivery and Biodistribution of Cisplatin in Vivo. Mol
Pharm. 13:2677–2682. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Raudenska M, Balvan J, Fojtu M, Gumulec J
and Masarik M: Unexpected therapeutic effects of cisplatin.
Metallomics. 11:1182–1199. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Trimmer EE and Essigmann JM: Cisplatin.
Essays Biochem. 34:191–211. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Qi R, Xiao H, Wu S, Li Y, Zhang Y and Jing
X: Design and delivery of camplatin to overcome cisplatin drug
resistance. J Mater Chem B Mater Biol Med. 3:176–179. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Telli ML, Stover DG, Loi S, Aparicio S,
Carey LA, Domchek SM, Newman L, Sledge GW and Winer EP: Homologous
recombination deficiency and host anti-tumor immunity in
triple-negative breast cancer. Breast Cancer Res Treat. 171:21–31.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kurz T, Leake A, von Zglinicki T and Brunk
UT: Lysosomal redox-active iron is important for oxidative
stress-induced DNA damage. Ann N Y Acad Sci. 1019:285–288. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Schieber M and Chandel NS: ROS function in
redox signaling and oxidative stress. Curr Biol. 24:R453–R462.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jiang P, Du W and Wu M: Regulation of the
pentose phosphate pathway in cancer. Protein Cell. 5:592–602. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kwon DH, Lee H, Park C, Hong SH, Hong SH,
Kim GY, Cha HJ, Kim S, Kim HS, Hwang HJ, et al: Glutathione Induced
Immune-Stimulatory Activity by Promoting M1-Like Macrophages
Polarization via Potential ROS Scavenging Capacity. Antioxidants.
8:E4132019. View Article : Google Scholar
|
|
14
|
Li J, Dong J, Li S, Xia W, Su X, Qin X,
Chen Y, Ding H, Li H, Huang A, et al: An alternative
microRNA-mediated post-transcriptional regulation of GADD45A by p53
in human non-small-cell lung cancer cells. Sci Rep. 7:71532017.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu LQ, Tian FJ, Xiong Y, Zhao Y and Song
JB: Gadd45a gene silencing by RNAi promotes cell proliferation and
inhibits apoptosis and senescence in skin squamous cell carcinoma
through the p53 signaling pathway. J Cell Physiol. 233:7424–7434.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhan Q, Chen IT, Antinore MJ and Fornace
AJ Jr: Tumor suppressor p53 can participate in transcriptional
induction of the GADD45 promoter in the absence of direct DNA
binding. Mol Cell Biol. 18:2768–2778. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wingert S, Thalheimer FB, Haetscher N,
Rehage M, Schroeder T and Rieger MA: DNA-damage response gene
GADD45A induces differentiation in hematopoietic stem cells without
inhibiting cell cycle or survival. Stem Cells. 34:699–710. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hollander MC, Kovalsky O, Salvador JM, Kim
KE, Patterson AD, Haines DC and Fornace AJ Jr:
Dimethylbenzanthracene carcinogenesis in Gadd45a-null mice is
associated with decreased DNA repair and increased mutation
frequency. Cancer Res. 61:2487–2491. 2001.PubMed/NCBI
|
|
19
|
Chen H, Shan J, Chen D, Wang R, Qi W, Wang
H, Ke Y, Liu W and Zeng X: CtIP promotes G2/M arrest in
etoposide-treated HCT116 cells in a p53-independent manner. J Cell
Physiol. 234:11871–11881. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang Y, Yuan Y, Liang P, Zhang Z, Guo X,
Xia L, Zhao Y, Shu XS, Sun S, Ying Y, et al: Overexpression of a
novel candidate oncogene KIF14 correlates with tumor progression
and poor prognosis in prostate cancer. Oncotarget. 8:45459–45469.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Krushkal J, Zhao Y, Hose C, Monks A,
Doroshow JH and Simon R: Concerted changes in transcriptional
regulation of genes involved in DNA methylation, demethylation, and
folate-mediated one-carbon metabolism pathways in the NCI-60 cancer
cell line panel in response to cancer drug treatment. Clin
Epigenetics. 8:732016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
De Feudis P, Debernardis D, Beccaglia P,
Valenti M, Graniela Siré E, Arzani D, Stanzione S, Parodi S,
D'Incalci M, Russo P, et al: DDP-induced cytotoxicity is not
influenced by p53 in nine human ovarian cancer cell lines with
different p53 status. Br J Cancer. 76:474–479. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Delmastro DA, Li J, Vaisman A, Solle M and
Chaney SG: DNA damage inducible-gene expression following platinum
treatment in human ovarian carcinoma cell lines. Cancer Chemother
Pharmacol. 39:245–253. 1997.PubMed/NCBI
|
|
24
|
Tarrade S, Bhardwaj T, Flegal M, Bertrand
L, Velegzhaninov I, Moskalev A and Klokov D: Histone H2AX Is
Involved in FoxO3a-Mediated Transcriptional Responses to Ionizing
Radiation to Maintain Genome Stability. Int J Mol Sci.
16:29996–30014. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Celeste A, Difilippantonio S,
Difilippantonio MJ, Fernandez-Capetillo O, Pilch DR, Sedelnikova
OA, Eckhaus M, Ried T, Bonner WM and Nussenzweig A: H2AX
haploinsufficiency modifies genomic stability and tumor
susceptibility. Cell. 114:371–383. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bassing CH, Suh H, Ferguson DO, Chua KF,
Manis J, Eckersdorff M, Gleason M, Bronson R, Lee C and Alt FW:
Histone H2AX: A dosage-dependent suppressor of oncogenic
translocations and tumors. Cell. 114:359–370. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Banerjee K, Ganguly A, Chakraborty P,
Sarkar A, Singh S, Chatterjee M, Bhattacharya S and Choudhuri SK:
ROS and RNS induced apoptosis through p53 and iNOS mediated pathway
by a dibasic hydroxamic acid molecule in leukemia cells. Eur J
Pharm Sci. 52:146–164. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen H, Liao K, Cui-Zhao L, Qiang-Wen F,
Feng-Zeng X, Ping-Wu F, Liang-Guo S and Juan-Chen Y: Cigarette
smoke extract induces apoptosis of rat alveolar Type II cells via
the PLTP/TGF-β1/Smad2 pathway. Int Immunopharmacol. 28:707–714.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Grossi V, Forte G, Sanese P, Peserico A,
Tezil T, Lepore Signorile M, Fasano C, Lovaglio R, Bagnulo R,
Loconte DC, et al: The longevity SNP rs2802292 uncovered: HSF1
activates stress-dependent expression of FOXO3 through an intronic
enhancer. Nucleic Acids Res. 46:5587–5600. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mah LJ, El-Osta A and Karagiannis TC:
gammaH2AX: A sensitive molecular marker of DNA damage and repair.
Leukemia. 24:679–686. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen HHW, Song IS, Hossain A, Choi MK,
Yamane Y, Liang ZD, Lu J, Wu LY, Siddik ZH, Klomp LW, et al:
Elevated glutathione levels confer cellular sensitization to
cisplatin toxicity by up-regulation of copper transporter hCtr1.
Mol Pharmacol. 74:697–704. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lan D, Wang L, He R, Ma J, Bin Y, Chi X,
Chen G and Cai Z: Exogenous glutathione contributes to cisplatin
resistance in lung cancer A549 cells. Am J Transl Res.
10:1295–1309. 2018.PubMed/NCBI
|
|
33
|
Tonigold M, Rossmann A, Meinold M, Bette
M, Märken M, Henkenius K, Bretz AC, Giel G, Cai C, Rodepeter FR, et
al: A cisplatin-resistant head and neck cancer cell line with
cytoplasmic p53(mut) exhibits ATP-binding cassette transporter
upregulation and high glutathione levels. J Cancer Res Clin Oncol.
140:1689–1704. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Okuno S, Sato H, Kuriyama-Matsumura K,
Tamba M, Wang H, Sohda S, Hamada H, Yoshikawa H, Kondo T and Bannai
S: Role of cystine transport in intracellular glutathione level and
cisplatin resistance in human ovarian cancer cell lines. Br J
Cancer. 88:951–956. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cadoni E, Valletta E, Caddeo G, Isaia F,
Cabiddu MG, Vascellari S and Pivetta T: Competitive reactions among
glutathione, cisplatin and copper-phenanthroline complexes. J Inorg
Biochem. 173:126–133. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Mailloux RJ, Craig Ayre D and Christian
SL: Induction of mitochondrial reactive oxygen species production
by GSH mediated S-glutathionylation of 2-oxoglutarate
dehydrogenase. Redox Biol. 8:285–297. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yang Y, Su Y, Wang D, Chen Y, Wu T, Li G,
Sun X and Cui L: Tanshinol Attenuates the Deleterious Effects of
Oxidative Stress on Osteoblastic Differentiation via Wnt/FoxO3a
Signaling. Oxid Med Cell Longev. 2013:3518952013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Liu J, Jiang G, Mao P, Zhang J, Zhang L,
Liu L, Wang J, Owusu L, Ren B, Tang Y, et al: Down-regulation of
GADD45A enhances chemosensitivity in melanoma. Sci Rep. 8:41112018.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang X, Zou F, Zhong J, Yue L, Wang F, Wei
H, Yang G, Jin T, Dong X, Li J, et al: Secretory Clusterin Mediates
Oxaliplatin Resistance via the Gadd45a/PI3K/Akt Signaling Pathway
in Hepatocellular Carcinoma. J Cancer. 9:1403–1413. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sekhar SC, Venkatesh J, Cheriyan VT, Muthu
M, Levi E, Assad H, Meister P, Undyala VV, Gauld JW and Rishi AK: A
H2AX-CARP-1 Interaction Regulates Apoptosis Signaling Following DNA
Damage. Cancers (Basel). 11:E2212019. View Article : Google Scholar
|
|
41
|
Salzano M, Sanz-García M, Monsalve DM,
Moura DS and Lazo PA: VRK1 chromatin kinase phosphorylates H2AX and
is required for foci formation induced by DNA damage. Epigenetics.
10:373–383. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wang Y, Kuramitsu Y, Kitagawa T, Tokuda K,
Baron B, Akada J and Nakamura K: The Histone Deacetylase Inhibitor
Valproic Acid Sensitizes Gemcitabine-Induced Cytotoxicity in
Gemcitabine-Resistant Pancreatic Cancer Cells Possibly Through
Inhibition of the DNA Repair Protein Gamma-H2AX. Target Oncol.
10:575–581. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Tang XH, Li H, Zheng XS, Lu MS, An Y and
Zhang XL: CRM197 reverses paclitaxel resistance by inhibiting the
NAC-1/Gadd45 pathway in paclitaxel-resistant ovarian cancer cells.
Cancer Med. 8:6426–6436. 2019. View Article : Google Scholar : PubMed/NCBI
|
